These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17047253)
1. Is ultrafiltration with icodextrin higher in diabetics than in nondiabetics? Jeloka TK; Oreopoulos DG Perit Dial Int; 2006; 26(6):729-30. PubMed ID: 17047253 [No Abstract] [Full Text] [Related]
2. Recommendations for the use of icodextrin in peritoneal dialysis patients. Johnson DW; Agar J; Collins J; Disney A; Harris DC; Ibels L; Irish A; Saltissi D; Suranyi M Nephrology (Carlton); 2003 Feb; 8(1):1-7. PubMed ID: 15012742 [TBL] [Abstract][Full Text] [Related]
3. Exploring new evidence of the clinical benefits of icodextrin solutions. Davies SJ Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii47-50. PubMed ID: 16825261 [TBL] [Abstract][Full Text] [Related]
4. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution. Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820 [TBL] [Abstract][Full Text] [Related]
5. Management of patients with recurrent nephrosis and intractable edema by intraperitoneal instillation of icodextrin solution. Morimoto S; Takahashi N; Kikuchi S; Yamahara H; Imada T; Kohno K; Masaki H; Nishikawa M; Iwasaka T Perit Dial Int; 2008; 28(5):559-62. PubMed ID: 18708557 [No Abstract] [Full Text] [Related]
6. Double-dose icodextrin to increase ultrafiltration in PD patients with inadequate ultrafiltration. Ballout A; Garcia-Lopez E; Struyven J; Maréchal C; Goffin E Perit Dial Int; 2011; 31(1):91-4. PubMed ID: 21282388 [No Abstract] [Full Text] [Related]
7. Alternative dialysis strategies with icodextrin. Panzer SE; Teitelbaum I Contrib Nephrol; 2012; 178():11-15. PubMed ID: 22652709 [TBL] [Abstract][Full Text] [Related]
8. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871 [TBL] [Abstract][Full Text] [Related]
9. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years. Posthuma N; Verbrugh HA; Donker AJ; van Dorp W; Dekker HA; Peers EM; Oe PL; ter Wee PM Perit Dial Int; 2000; 20(2):174-80. PubMed ID: 10809240 [TBL] [Abstract][Full Text] [Related]
10. Peritoneal clearance of homocysteine with icodextrin or standard glucose solution exchange. Czupryniak A; Nowicki M; Chwatko G; Jander A; Bald E Nephrology (Carlton); 2005 Dec; 10(6):571-5. PubMed ID: 16354239 [TBL] [Abstract][Full Text] [Related]
11. [Peritoneal equilibrium test using icodextrin and glucose at different concentrations]. Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Gallego T; Delgado-Pecellín C; Benítez M; Torán CD Nefrologia; 2002; 22(4):340-7. PubMed ID: 12369125 [TBL] [Abstract][Full Text] [Related]
12. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis]. Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197 [TBL] [Abstract][Full Text] [Related]
14. Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis. Nakamoto H; Babazono T; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Yorioka N; Sato M; Yamabe K; Kawaguchi Y Adv Perit Dial; 2005; 21():168-74. PubMed ID: 16686312 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange. Davies SJ; Garcia Lopez E; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimburger O; Simonsen O; Davenport A; Lindholm B; Tranaeus A; Divino Filho JC Nephrol Dial Transplant; 2008 Sep; 23(9):2982-8. PubMed ID: 18456678 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Davies SJ; Brown EA; Frandsen NE; Rodrigues AS; Rodriguez-Carmona A; Vychytil A; Macnamara E; Ekstrand A; Tranaeus A; Filho JC; Kidney Int; 2005 Apr; 67(4):1609-15. PubMed ID: 15780118 [TBL] [Abstract][Full Text] [Related]
17. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone. Jenkins SB; Wilkie ME Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201 [TBL] [Abstract][Full Text] [Related]
18. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Posthuma N; ter Wee PM; Verbrugh HA; Oe PL; Peers E; Sayers J; Donker AJ Nephrol Dial Transplant; 1997 Mar; 12(3):550-3. PubMed ID: 9075139 [TBL] [Abstract][Full Text] [Related]
19. Peritoneal Water Transport Characteristics of Diabetic Patients Undergoing Peritoneal Dialysis: A Longitudinal Study. Fernandes A; Ribera-Sanchez R; Rodríguez-Carmona A; López-Iglesias A; Leite-Costa N; Pérez Fontán M Am J Nephrol; 2017; 46(1):47-54. PubMed ID: 28633134 [TBL] [Abstract][Full Text] [Related]
20. When should icodextrin be started to improve atherosclerosis in peritoneal dialysis patients? Hiramatsu T; Hayasaki T; Hobo A; Furuta S; Kabu K; Tonozuka Y; Iida Y Adv Perit Dial; 2013; 29():4-8. PubMed ID: 24344482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]